Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...
This repeated cross-sectional study including 69.2 million obesity management drug dispensed prescriptions revealed an increase from 0.76 million in July 2017 to 1.5 million in February 2024, with an ...
The approved dose of Niktimvo for adults and pediatric patients weighing at least 40 kg is 0.3 mg/kg, up to a maximum dose of 35 mg, as an intravenous infusion over 30 minutes every two weeks.
River Hawk Scholars Academy (RHSA) is excited to announce that we are seeking partnerships with interested research faculty for the 2025–26 academic year as part of our Roads to Research program. The ...
AHEAD of the official release of the December 2024 headline inflation rate by the National Bureau of Statistics (NBS), CAPE Economic Research ... inflation rate to hit 35.3 percent.
Peptides have emerged as a focal point in molecular and biological research, providing a promising avenue for understanding and influencing cardiac function. Composed of short chains of amino acids, ...
Department of Chemistry and the Beckman Institute for Advanced Science and Technology, University of Illinois Urbana─Champaign, Urbana, Illinois 61801, United States Department of Evolution, Ecology, ...
Scientists have long known that light can sometimes appear to exit a material before entering it -- an effect dismissed as an illusion caused by how waves are distorted by matter. Now, researchers at ...
The N-terminal pro–B-type natriuretic peptide (NT-proBNP ... and a pulmonary arterial systolic pressure of 65 mm Hg (normal, <35). How would you further evaluate and treat this patient?
The research noted that this significant muscle loss can be mostly due to the extent of weight reduction, rather than an independent effect. Changes in lean body mass with glucagon-like peptide-1 ...
Eli Lil­ly has asked to in­ter­vene in lit­i­ga­tion be­tween a com­pound­ing phar­ma­cy trade group and the FDA over the agency’s de­ci­sion to re­move Lil­ly’s block­buster … ...
In terms of drug sales buoying those company rankings, Lilly’s tirzepatide drugs and Novo’s semaglutide franchise are expected to reel in more than $70 billion in combined sales this year.